Ablative Solutions’ Infusion Catheter Snags CE Mark

Ablative Solutions’s Peregrine system infusion catheter for hypertension has won CE Mark approval, the Kalamazoo, Calif., devicemaker announced Wednesday.

The device works by infusing a neurolytic agent into the perivascular space surrounding the renal artery, which targets high blood pressure-causing sympathetic nerves. The company has begun enrolling drug-resistant hypertension patients in a European clinical trial.

The devicemaker also plans a trial in the U.S., where the product has been designated investigational use only for hypertension. — Jason Scott